Skip to main content

Zoetis Inc. statistics

  • ZTS · NYSE
  • Pharmaceuticals
  • S&P 500
$83.82+1.04%Close 13 Nov 2026

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Enterprise value$41.86B
EV / EBITDA10.74
EV / sales4.41

Share price

Latest close$83.82
Day's change+1.0%
52-week high$132.49
52-week low$68.77
From 52-week high−36.7%
Return · 1 month+5.6%
Return · 3 months+11.7%
Return · year to date−33.4%
Return · 1 year−30.9%
Beta · 1 year against the S&P 5000.61
50-day average$76.29
200-day average$91.48
RSI 1458.9
Average volume · 20 sessions4.5M

Margins and returns

For fiscal 2025, as filed.

Gross margin71.8%
Operating margin37.5%
Net margin28.2%
Free cash flow margin24.1%
Return on equity65.3%
Return on assets19.0%
Return on invested capital26.7%
Return on capital employed29.4%
Stock-based compensation / revenue0.9%

Financial position

At the end of fiscal 2025.

Cash and equivalents$2.45B
Total debt$9.29B
Net debt$6.84B
Current ratio3.12
Debt / equity2.72
Net debt / EBITDA1.70
Interest coverage15.97

Shares and dividends

For fiscal 2025, as filed.

Diluted shares444M
Net share repurchases$3.23B
Dividends per share$2.03
Dividend payout33.3%

Taxes

For fiscal 2025, as filed.

Income tax expense$687.0M
Effective tax rate20.4%

ZTS in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.